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Dendritic polymer imaging systems for the
evaluation of conjugate uptake and cleavage†
Harald R. Krüger, Gregor Nagel, Stefanie Wedepohl and Marcelo Calderón*
Fluorescent turn-on probes combined with polymers have a broad range of applications, e.g. for intra-
cellular sensing of ions, small molecules, or DNA. In the ﬁeld of polymer therapeutics, these probes can
be applied to extend the in vitro characterization of novel conjugates beyond cytotoxicity and cellular
uptake studies. This is particularly true in cases in which polymer conjugates contain drugs attached by
cleavable linkers. Better information on the intracellular linker cleavage and drug release would allow a
faster evaluation and optimization of novel polymer therapeutic concepts. We therefore developed a ﬂu-
orescent turn-on probe that enables direct monitoring of pH-mediated cleavage processes over time.
This is achieved by exploiting the ﬂuorescence resonance energy transfer (FRET) between two dyes that
have been coupled to a dendritic polymer. We demonstrate the use of this probe to evaluate polymer
uptake and intracellular release of cargo in a cell based microplate assay that is suitable for high through-
put screening.
Introduction
The field of polymer therapeutics is evolving rapidly and thus
producing a multitude of diﬀerent drug delivery systems
(DDS).1 In general, these systems are composed of watersolu-
ble polymers that act as inert functional nanocarriers to
improve the delivery of drugs, imaging agents, proteins, or
genes.2 Polymer–drug conjugates can overcome the limitations
of small molecule drugs due to a reduced body clearance,
passive targeting, and controlled drug release all leading to a
higher concentration of drugs at the site of action and mini-
mized toxic side eﬀects.3
After systemic application polymer–drug conjugates typi-
cally accumulate in solid tumors via the enhanced permeation
and retention (EPR) eﬀect.4,5 They are taken up by cancer cells
through endocytosis, which can be receptor mediated, adsorp-
tive, or through the fluid-phase.3 During endocytosis a signifi-
cant drop in the pH value takes place from the physiological
value (7.2–7.4) to 6.5–5.0 in the endosomes and to around 4.0
in the primary and secondary lysosomes. This drop in the pH
was shown to be useful for triggering intracellular drug release
from pH-sensitive nanocarriers.3 Many acid cleavable bonds
like hydrazones, acetals, and imines have been extensively
explored as linkers between drugs and polymers.6
Imaging agents (fluorescent dyes, radionuclides, etc.) can
be used in the same manner as drugs for conjugation to poly-
meric nanocarriers. Among the diﬀerent imaging approaches,
fluorescence resonance energy transfer (FRET) has been
demonstrated to be a valuable tool for functional imaging in
therapy and diagnosis.7 The distance dependence makes
FRET-based probes ideal for determining bond cleavage or
changes in structural conformations of biomolecules.8 FRET-
based imaging is a powerful technique because it provides
functional imaging with real time information and high sensi-
tivity within intracellular milieu, e.g. monitoring of apoptosis,9
enzyme activity,10 or ion sensing.11,12 Therefore, FRET-based
applications may oﬀer information on the release kinetics,
which is crucial for the design of DDS.7,13 In this regard versa-
tile but complex nanoparticles which unite diﬀerent imaging
approaches and functional imaging through FRET have been
reported.14 They succeeded in providing detailed information
achieved through ad hoc systems, e.g. studies of drug release
through cleavage of crosslinked micelles,15 release of a conju-
gated drug from a quantum dot or gold nanoparticles,16 and
release by diﬀusion of the encapsulated drug from meso-
porous silica nanoparticles.17 However, most of the reported
systems are limited in terms of screening of multiple
materials.
Gathering information about successful delivery and intra-
cellular drug release of polymer–drug conjugates before
expensive and time consuming in vivo investigations are per-
formed, is of great importance. Cytotoxicity assays and
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fluorescence microscopy are nowadays the main tools for eval-
uating the performance of DDS in vitro. Although they provide
valuable information, e.g. cytotoxicity and details about intra-
cellular fate, these assays do not allow correlation of the per-
formance of DDS with their cellular uptake and drug release.
Herein, we present a turn-on probe that overcomes the
aforementioned limitation and enables the fast and simul-
taneous screening of DDS in a simple cell-based microplate
assay. The probe comprises a fluorescent donor and an accep-
tor dye (indocarbocyanine [ICC] and indodicarbocyanine
[IDCC], respectively) that were linked in close proximity
through a trifunctional linker to dendritic polyglycerol (dPG).
The fluorescence of the donor dye is quenched via intra-
molecular FRET until it is released by cleavage of the acid labile
linker to the polymer. This allows one to monitor an increas-
ing fluorescence signal upon dye release in real time, re-
presenting the liberation of cargo. We demonstrate the use of
this concept in a cell-based microplate assay format, which




The chemicals used were all commercially available from
Aldrich, Acros Organics, Invitrogen, and mivenion GmbH and
did not require further purification. All solvents were distilled
before usage or purchased dry and in p.a. quality. For prepara-
tive work only distilled water and Milli-Q water obtained from
a Millipore system were used. Dry solvents were taken from a
MB SPS 800 solvent system from MBraun.
Instruments
1H and 13C NMR spectra were recorded on a Jeol ECX-400
(400 MHz 1H-NMR and 176 MHz 13C-NMR) spectrometer or a
BrukerBioSpin (700 MHz) instrument at room temperature,
and chemical shift values (δ) are given in ppm relative to the
internal standard MeOD-d4 1H-NMR spectra (3.31 ppm), 13C
NMR spectra (49.0 ppm). MS ESI-ToF analyses were performed
on an Agilent 6210 ESI-TOF, Agilent Technologies, Santa Clara,
CA, USA. The fluorescence spectra were recorded on a Jasco
FP-6500 spectrofluorometer. UV/Vis spectra were recorded on a
Scinco S-3100 spectrometer. The cell-based assay was per-
formed on a Tecan InfiniteM200 Pro microplate reader
equipped with a gas control module. For microscopy we used a
Leica SP8 confocal laser scanning microscope and LASAF soft-
ware. The flow cytometric studies were performed with a FACS-
Canto II flow cytometer (BD Biosciences).
Synthetic procedures
The dPG (average MW 200 kDa, PDI = 1.6, Fig. S1†) was pre-
pared according to a slightly modified protocol in an emulsion
as described earlier.18 Polyglycerolazide with 1% of the total
hydroxyl groups bearing azido groups was prepared as pre-
viously described.19 Briefly, polyglycerolazide was prepared
according to a two-step protocol starting from dPG with con-
version of the OH groups into mesyl (Ms) groups followed by
transformation of the Ms groups into azide (N3) functionalities
(Scheme S1, ESI†). The ICC dyes and IDCC dye (Fig. S2, ESI†)
were purchased from mivenion GmbH and synthesized follow-
ing literature procedures.20,21 The detailed synthetic pro-
cedures of the dye and conjugate synthesis can be found in
the ESI.†
Cell viability assay
Cell viability was determined by the CellTiter-Glo® Lumines-
cent Cell Viability Assay (Promega) according to the manufac-
turer’s protocol. After 24 hours of incubation in a serum free
medium at a concentration 1 mg mL−1 of conjugates, the viabi-
lity was about 75%.
Fluorescence analysis
The FRET conjugates (10 nM) were incubated in buﬀers of
various pH (4, 5, and 7.4) at 37 °C in a 96-well plate and in
a quartz cuvette. A 50 mM phosphate buﬀer (PB) was used
for pH 5 and 7.4 and a 50 mM acetate buﬀer was used for
pH 4. The plate was then placed in the microplate reader.
Fluorescence was recorded every 15 minutes at an excitation
wavelength of 540 nm (9 nm bandwidth) and an emission wave-
length of 580 nm (20 nm bandwidth). Average values from the
triplicates were plotted in the graph. Additionally, the fluo-
rescence spectra were recorded after 30 min, 1, 2, 4, 8, and 24 h
with a spectrofluorometer to obtain the full fluorescence spectra.
Cell based microplate assay
A549 lung epithelial cancer cells were routinely maintained in
DMEM (Life Technologies) with 10% FCS (Biochrom AG,
Berlin, Germany) and 1% penicillin/streptomycin (Life Techno-
logies) at 37 °C and 5% CO2. For the assay, 10 000 cells per
well were seeded into 96-well plates and grown overnight. Each
96-well plate contained wells without cells as a control. The
next day, cells were washed 3 times with PBS, and 50 µL per
well DMEM without FCS and without phenol red was added.
For inhibition of cellular uptake, 50 µL of 40 mM methyl-
β-cyclodextrin (Sigma) in DMEM was added to the respective
wells, giving a final concentration of 20 mM, and incubated
Scheme 1 Top: schematic illustration showing the mode of action of a
FRET conjugate inducing a ﬂuorescence signal upon uptake and release.
Bottom: illustration of the plate reader assay related to the mode of
action of the FRET conjugate.
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for 15 minutes at 37 °C. After incubation, the respective wells
were washed 3 times with 200 µL per well PBS and the com-
pounds were added to final concentrations of 1 mg mL−1 in
DMEM to the cells, to wells without cells, or in a pH buﬀer of
4 or 7, each of which was triplicated. Wells, which had been treated
with methyl-β-cyclodextrin, were also given Lovastatin (Sigma)
with a final concentration of 0.4 µg mL−1. The plates were then
placed in the microplate reader, which was equilibrated to
37 °C and 5% CO2. Fluorescence was recorded every
15 minutes at an excitation wavelength of 540 nm (9 nm band-
width) and an emission wavelength of 580 nm (20 nm band-
width). Average values from the triplicates of the control wells
without cells were subtracted from the wells with cells and the
diﬀerence to time point 0 was calculated from the graph. The
assay was independently repeated two times to calculate error bars.
Results and discussion
Synthetic strategy for the FRET conjugates
To create an eﬃcient FRET system for monitoring the bond
cleavage between a polymeric nanocarrier and a cargo, we fol-
lowed a modular approach that allowed us to covalently link
dPG to two fluorescent dyes in near proximity. Fig. 1 shows the
modular design, which comprises dPG as the polymer nano-
carrier, lysine attached to the acceptor dye as the trifunctional
linker, and the donor dye linked through a pH-sensitive bond.
We chose a commonly known FRET pair of two fluorescent
dyes, namely ICC and IDCC. These two dyes showed a suitable
degree of spectral overlap between the ICC emission and IDCC
absorption spectra, a suitable Förster distance, and suﬃcient
spatial separation of the emission wavelengths for accurate
detection.22 We chose dPG as an example of a nanocarrier
because it exhibits good chemical stability, inertness under
biological conditions, high biocompatibility, and excellent
water solubility. Additionally, dPGs enable selective function-
alization of reactive groups, which lead to controllable load-
ings of bioactive molecules.23–25 These properties open a
broad range of potential applications in medicine and
pharmacology, i.e. as polymeric nanocarriers, antifouling coat-
ings of biomaterials, targeting moieties, etc.26
The hydrazone bond was chosen as a pH-sensitive linker to
the donor dye ICC due to its proven suitability and adjustable
stability against pH-mediated hydrolysis.6 With such a con-
figuration, it was expected that, upon irradiation of the probe,
the fluorescence energy would have been transferred from ICC
to IDCC, thereby quenching the ICC fluorescence. Once the
acid labile linker cleaved, the ICC should be released, thereby
leading to an increase of its fluorescence emission intensity.
The synthetic strategy consists of three consecutive steps:
(a) synthesis of the IDCC-labeled tri-functional linker, (b) coupling
of the fluorescent linker to the dendritic polymer nanocarrier,
and (c) coupling of the pH-sensitive ICC-EMCH linker.
Synthesis of the precursor polymer conjugate
The first step was to prepare the IDCC-labelled polymer pre-
cursor with an amino group in near proximity for a later thio-
lation and thiol–ene click linkage with the EMCH-ICC dyes
(Scheme 2). The precursor conjugate was prepared by following
procedures previously reported by our group.27
Briefly, the fluorenylmethyloxycarbonyl (Fmoc) and tert-
butyloxycarbonyl (Boc) di-protected amino acid lysine 1 was
coupled to propargyl amine through the carboxyl group of the
lysine via amide bond formation. After Fmoc deprotection the
IDCC dye was introduced via amide bond formation by an
amino-acid coupling strategy. Boc deprotection using trifluoro-
acetic acid (TFA) gave a free primary amine 3. The IDCC dye-
labelled linker derivatives were purified by reversed phase
column chromatography and characterized by 1H-NMR,
13C-NMR, UV-Vis spectroscopy, and MS ESI-ToF. The conju-
gation of the alkyne and the dye containing linker construct 3
to the polymeric carrier dPG (average MW 200 kDa) was per-
formed using copper catalyzed Huisgen 1,3-dipolar cyclo-
addition. The product 4 was purified by ultrafiltration using
water as a solvent with one running-cycle with an EDTA solu-
tion to remove all the copper content. The conjugate was
obtained in 62% yield and characterized by UV-Vis and fluo-
rescence spectroscopy, and fast protein liquid chromatography
(FPLC) using a Sephacryl S-100 column.
Synthesis of the pH-sensitive ICC-EMCH linker
For the second synthetic stage we first screened hydrazone-
bearing ICC derivatives with optimal pH-stability profiles for
Fig. 1 A modular approach followed for synthesis of the FRET conjugates.
Scheme 2 Synthesis of the IDCC labelled precursor polymer
conjugate.
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specific intracellular cleavage. The dyes were provided with
maleimido groups for the further coupling to the dendritic
nanocarrier 4. Three ICC carbonyl derivatives with diﬀerent
substitutions in the α-position were synthesized (5a, 6b, and
7a in Scheme 3) as precursors of hydrazone bonds with
diﬀerent stabilities against pH-mediated hydrolysis. (6-Male-
imidocaproyl)hydrazine (EMCH) was used as a linker because
of its suitable pH-stability profile as earlier reported for other
DDS.3 Therefore, as shown in Scheme 3, two commercially
available ICC derivatives were used to form an amide bond
with diﬀerent carbonyl compounds, i.e. piperidone, amino-
acetaldehyde, and 4-acetylbenzoic acid. The secondary amine
of piperidone was used to form an amide bond with ICC
carboxylic acid. For this purpose, the coupling reagent O-(7-
azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexa-
fluorophosphate (HATU) was applied to form an active ester
with the acid in situ. Subsequently, piperidone was added to
obtain the target product 5a with a yield of 50%. The synthesis
of the second derivative started with the same ICC carboxylic
acid but was coupled with the primary amine of aminoacetal-
dehyde dimethylacetal to yield 65% of the protected aldehyde
6a. The last variant started with an amino derivative of ICC.
The amino group was used to form an amide bond with 4-acet-
ylbenzoic acid to yield 79% of ICC-4-acetylbenzamido 7a
(Scheme 3). In all three cases the carboxylic acid was dissolved
together with HATU in a DMF–methanol mixture and DIPEA.
This reaction mixture was stirred for 30 minutes to form the
active ester. Subsequently the amine compounds were added.
After reaction completion the crude products were precipitated
in diethyl ether, centrifuged, and the residues were purified
using a reversed-phase chromatography column. All com-
pounds were characterized by 1H-NMR and mass spectrometry.
The next step was the formation of the hydrazone with the
EMCH linker and the diﬀerent ICC carbonyl derivatives
(Scheme 3). The protected aldehyde 6a was first deprotected
under acidic conditions using a catalytic amount of TFA in
water. The crude product was purified by reversed phase
chromatography. The product 6b was characterized by
1H-NMR and mass spectrometry. It was obtained with a yield
of 76%. The hydrazone synthesis was performed in extra dry
methanol and a catalytic amount of TFA. The crude products
were purified by reversed-phase chromatography where a
quick purification was enforced to avoid the reverse reaction
due to water as the eluent. The yield for the ICC-4-oxopipri-
done-EMCH 5b was determined to be 49%, for the ICC-acet-
aldehyde-EMCH 7c 43%, and the ICC-4-acetylbenzamido
derivative 7b was obtained in 82% yield. Products 5b, 6c, and
7b were characterized by MS ESI-ToF and by 1H-NMR spec-
troscopy. To quickly assess the stability against hydrolysis in
pH 4 and 7.4, a preliminary thin layer chromatography (TLC)
study of the three hydrazone derivatives of the ICC dye was per-
formed. It was observed that, as the stability of the hydrazone
bond against hydrolysis increased, the rate of dye release
decreased. The linker 5b degraded rapidly at both pH values,
rendering this piperidone derivative unsuitable for further
investigation. The other two linkers 6c and 7b showed
suﬃcient stability at pH 7.4 as expected for linkers used in
DDS. The 4-acetylbenzamido derivative 7b showed higher
stability at pH 7.4 and was therefore selected as the ideal build-
ing block for the FRET conjugate.
Synthesis of FRET conjugates
In order to synthesize the functional FRET conjugate and a
non-cleavable control, the ICC-EMCH linker 7b or a stable ICC
maleimide derivative (ICC-mal, see Fig. S2, ESI†) was conju-
gated to the precursor polymer conjugate 4 as shown in
Scheme 4. Therefore, the free amino group of 4 was thiolated
with 2-iminothiolane in (PB) pH 7.4 to yield the conjugate 8.
The resulting thiol was attached either to the maleimido group
of the ICC-EMCH 7b or to the ICC-mal by Michael addition
in DMSO. The reaction mixtures were purified using FPLC
with a Sephacryl S-100 column and lyophilized. The functional
FRET conjugate 9 and the non-cleavable FRET conjugate 10
were characterized by UV/Vis and fluorescence spectroscopy,
dynamic light scattering (DLS) and FPLC using a size exclusion
gel (Sephacryl S-100) after reconstitution in (PB) (Table 1 and
the synthetic part in the ESI†). A CellTiter-Glo® assay demon-
strated that neither the precursor polymer conjugate nor the
conjugation of the ICC dye significantly influenced the cell
viability (Fig. S3†).
Scheme 3 Synthesis of the hydrazone-bearing derivatives of ICC with diﬀerent pH-cleavability proﬁles.
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Evaluation of the FRET conjugates
In order to prove the feasibility of our system to monitor the
intracellular cleavage and dye release, the FRET conjugate was
incubated in buﬀer solutions at diﬀerent biologically relevant
pH values (4, 5, and 7.4) and the fluorescence intensity was
measured over time. As discussed above and depicted in
Fig. 2, the fluorescence intensity of the donor dye ICC should
increase over time upon pH-mediated cleavage of the hydra-
zone linker.
The fluorescence spectra of the conjugate 9 that was incu-
bated at pH 4 over time are shown in Fig. 3a. It shows a strong
increase in donor dye fluorescence at 568 nm and a reduction
of the acceptor induced peak at 667 nm over time. To confirm
that the increase of fluorescence was due to the pH mediated
cleavage of the hydrazone bond, the non-cleavable control 10
was investigated. As expected, the fluorescence spectra of 10
did not show any change in the intensity over time (Fig. 3b).
Fig. 3c and 3d summarize the fluorescence measurements of
the two conjugates at diﬀerent relevant pH values (4, 5, and
7.4). The normalized fluorescence intensity was plotted
against the time of incubation in the respective buﬀer
solution. It was observed that the fluorescence of the FRET-
probe and the corresponding control suﬀered only marginal
changes at pH 7.4, whereas the fluorescence of the functional
FRET conjugate 9 at pH 5 increased to a lesser extent when
compared to the results at pH 4. The quenching eﬃciency of
the FRET conjugate 9 was calculated to be 75% using eqn (S1)
(ESI†).
We demonstrate that our approach allows facile coupling of
the functional FRET moiety to a polymer containing a low
amount of azides, as well as the incorporation of a linker with
enough stability against hydrolysis. To a large extent this strat-
egy would allow the incorporation of diﬀerent linker modal-
ities, e.g. enzymatic or reductive cleavable linkers, to cover a
greater area of triggered release applications.
Fig. 2 Schematic illustration of the intramolecular FRET between ICC
and IDCC being disrupted upon pH mediated cleavage.
Scheme 4 Synthesis of the FRET conjugates starting from the precursor conjugate 4. Two consecutive conjugation reactions yield either the
functional (9) or the non-cleavable FRET conjugate 10.











Conjugate 9 0.29/0.11 1/0.4 200 1.6 12.5
Conjugate 10 0.24/0.12 1/0.5 200 1.6 12.1
aDetermined by UV/Vis-spectrometry using the absorption coeﬃcient
of the IDCC dye. b The average value determined by GPC. c The mean
hydrodynamic diameter as obtained by the size distribution by volume
via DLS measurements in PBS (pH 7.4).
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Utilization of the probe to monitor intracellular cargo release
According to our hypothesis the synthesized probes should
enable monitoring events like bond cleavage and cargo release
within acidic compartments of living cells. Moreover, we
thought that the probes could be applied in a high throughput
screening compatible microplate assay. To this end, A549
cancer cells were incubated with the FRET conjugate 9 on
96-well plates and grown inside a microplate reader which
recorded the fluorescence intensity of the ICC dye over time.
As a control for media eﬀects, which could possibly occur
independently of the cells, the same plate contained control
wells without cells but only the conjugates in cell culture
media. The fluorescence intensity values of these control wells
were subtracted from those of the wells containing cells.
Values were then calculated and expressed as a change relative
to the starting time point. A plot of the relative fluorescence
intensities over time with the background subtracted is shown
in Fig. 4. Fluorescence intensity of the ICC dye of the func-
tional conjugate steadily increased over time (Fig. 4, red line).
To confirm that this increase was due to pH mediated cleavage
of the hydrazone bond and thereby release of the ICC dye, we
included the non-cleavable conjugate 10 on the same 96-well
plate under identical conditions. This non-cleavable control
conjugate showed only a marginal increase of fluorescence
intensity over time (Fig. 4, green line). This result confirmed
that the regained fluorescence signal was due to the cleavage
of the ICC dye. To further prove that the bond was cleaved
within the cells after uptake, the 96-well plate also included
cells that had been pre-treated with endocytosis inhibitors
(Fig. 4, grey line). In this case the fluorescence intensity only
marginally increased, similar to the non-cleavable control.
Successful uptake and inhibition were confirmed by con-
focal microscopy and by flow cytometric studies (Fig. S4–S6,
ESI†). Due to the fact that the released ICC is not accumulating
intracellularly it could not be imaged with these methods.
Nevertheless, the results from the microplate reader highlight
the superior performance of the assay that enables monitoring
the sum of all cleavage events from 10 000 cells per well.
Altogether, these results confirmed that the increased fluo-
rescence seen in the turn-on probe 9, which was incubated on
and monitored over time in living cells, was due to an acidic
bond cleavage after cellular uptake. Therefore we have demon-
strated the application of our probe in a cell-based, real time,
and high throughput compatible microplate assay, which can
provide valuable insight into the event of bond cleavage in
cells and thus help to evaluate the performance of a polymeric
nanocarrier.
Conclusions
The comparison of DDS in terms of their eﬃciency is of great
importance to estimate whether novel nanocarriers are worth
future research. In the particular case of polymer–drug conju-
gates, information about intracellular linker cleavage and
release kinetics is crucial for the quick assessment of their
suitability.
In this paper, we have developed a turn-on probe which uti-
lizes the FRET phenomenon of the dyes ICC and IDCC
attached to a polymeric carrier to monitor the cleavage of a
linker and consequent release of a cargo. This functional poly-
meric probe was synthesized using a tri-functional alkyne and
IDCC containing linker and a pH labile, conjugatable (male-
imide bearing) ICC derivative. When the conjugate was cleaved,
the attached ICC dye was released and its fluorescence, which
had been quenched before, increased.
We suggest the use of this assay as a platform technology
for testing the performance of polymer–drug conjugates. For
this purpose, we showed that the probe could be applied in a
cell-based microplate assay that allowed real time monitoring
Fig. 4 Change in the ﬂuorescence intensities (in relative ﬂuorescence
units [RFU]) over time of the diﬀerent conjugates in a cell-based micro-
plate assay.
Fig. 3 Fluorescence analysis of the conjugates. (a, b) Fluorescence
spectra of the functional conjugate 9 and the non-cleavable control 10
incubated at pH 4, excited at 500 nm, over time. (c, d) The ﬂuorescence
intensity of the two conjugates (9 and 10, respectively) plotted over time
with incubation at diﬀerent relevant pH values (4, 5, and 7.4) in a micro-
plate reader.
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and high throughput approaches. It induced a signal when the
conjugate uptake occurred and the cargo was released. This
probe design can easily be applied to other polymers contain-
ing azide groups by attachment of the alkyne and IDCC con-
taining linker 3 and subsequent conjugation of the ICC-EMCH
derivative. Furthermore, both the cleavage modality and the
cell line can be varied, depending on the purpose of the
polymer conjugate which is investigated. This would enable
the rapid determination of structure–activity relationships of
various nanocarriers.
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